The Impact of COVID-19 is included in Exosome Therapeutics Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Exosome Therapeutics Trends and Forecast
The future of the global exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets. The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 25.7% from 2024 to 2030. The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Exosome Therapeutics by Segment
The study includes a forecast for the global exosome therapeutics by type, application, end use, and region.
Exosome Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Natural Exosome
• Hybrid Exosome
Exosome Therapeutics Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Metabolic Disorders
• Oncology
• Cardiac Disorders
• Neurology
• Inflammatory Disorders
• Organ Transplantation
• Gynecology Disorders
• Blood Disorders
• Others
Exosome Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Research & Academic Institutes
• Hospitals & Diagnostic Centers
Exosome Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Exosome Therapeutics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome therapeutics companies profiled in this report include-
• Church & Dwight
• GSK
• Pfizer
• Sun Pharmaceutical
• Takeda Pharmaceutical
• F. Hoffmann-La Roche
• Celgene Corporation
Exosome Therapeutics Market Insights
Lucintel forecasts that natural exosome will remain the largest segment over the forecast period due to as more abundant, easier to produce, more biocompatible, and have a longer shelf life than hybrid exosomes.
Within this market, research and academic institutes is expected to remain the larger segment due to high demand for exosome therapeutics research.
North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.
Features of the Global Exosome Therapeutics Market
Market Size Estimates: Exosome therapeutics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Exosome therapeutics market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Exosome therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the exosome therapeutics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the exosome therapeutics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the exosome therapeutics market size?
Answer: The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030.
Q.2 What is the growth forecast for exosome therapeutics market?
Answer: The global exosome therapeutics market is expected to grow with a CAGR of 25.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the exosome therapeutics market?
Answer: The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.
Q4. What are the major segments for exosome therapeutics market?
Answer: The future of the exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets.
Q5. Who are the key exosome therapeutics market companies?
Answer: Some of the key exosome therapeutics companies are as follows:
• Church & Dwight
• GSK
• Pfizer
• Sun Pharmaceutical
• Takeda Pharmaceutical
• F. Hoffmann-La Roche
• Celgene Corporation
Q6. Which exosome therapeutics market segment will be the largest in future?
Answer: Lucintel forecasts that natural exosome will remain the larger segment over the forecast period as it is abundant in nature, more biocompatible, and possess a longer shelf life than hybrid exosomes.
Q7. In exosome therapeutics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the exosome therapeutics market by type (natural exosome and hybrid exosome), application (metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others), end use (research & academic institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Exosome Therapeutics Market, Exosome Therapeutics Market Size, Exosome Therapeutics Market Growth, Exosome Therapeutics Market Analysis, Exosome Therapeutics Market Report, Exosome Therapeutics Market Share, Exosome Therapeutics Market Trends, Exosome Therapeutics Market Forecast, Exosome Therapeutics Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Exosome Therapeutics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Exosome Therapeutics Market by Type
3.3.1: Natural Exosome
3.3.2: Hybrid Exosome
3.4: Global Exosome Therapeutics Market by Application
3.4.1: Metabolic Disorders
3.4.2: Oncology
3.4.3: Cardiac Disorders
3.4.4: Neurology
3.4.5: Inflammatory Disorders
3.4.6: Organ Transplantation
3.4.7: Gynecology Disorders
3.4.8: Blood Disorders
3.4.9: Others
3.5: Global Exosome Therapeutics Market by End Use
3.5.1: Research & Academic Institutes
3.5.2: Hospitals & Diagnostic Centers
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Exosome Therapeutics Market by Region
4.2: North American Exosome Therapeutics Market
4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
4.3: European Exosome Therapeutics Market
4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
4.4: APAC Exosome Therapeutics Market
4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
4.5: ROW Exosome Therapeutics Market
4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use
6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region
6.2: Emerging Trends in the Global Exosome Therapeutics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Church & Dwight
7.2: GSK
7.3: Pfizer
7.4: Sun Pharmaceutical
7.5: Takeda Pharmaceutical
7.6: F. Hoffmann-La Roche
7.7: CELGENE Corporation
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Exosome Therapeutics Market Report.